Olmesartan medoxomil: current status of its use in monotherapy
Hans R BrunnerLausanne University, Lausanne and Medizinische Poliklik, Universitaetsspital, Basel, SwitzerlandAbstract: Olmesartan medoxomil is an angiotensin II receptor antagonist. In pooled analyses of seven randomized, double-blind trials, 8 weeks’ treatment with olmesartan medoxomil was s...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2006-12-01
|
| Saila: | Vascular Health and Risk Management |
| Sarrera elektronikoa: | https://www.dovepress.com/olmesartan-medoxomil-current-status-of-its-use-in-monotherapy-peer-reviewed-article-VHRM |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|